NIH Bioimaging Institute Will Receive One-Third Of NCRR Portfolio
This article was originally published in The Gray Sheet
Executive Summary
NIH's fledgling National Institute of Biomedical Imaging and Bioengineering (NIBIB) will receive roughly one-third of the research grants portfolio from the National Center for Research Resources, Michael Marron, PhD, director of NCRR's Division of Biomedical Technology, reported at a recent meeting.
You may also be interested in...
NIH Bioimaging Institute Act Leads Agency To Halt OBBB Director Search
NIH is seeking a director for its future National Institute of Biomedical Imaging and Bioengineering, scrapping the search for a leader for the office that had been planned to oversee those activities prior to President Clinton's approval of the institute.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.